Aims : to test the clinical knowledge of participants in thoracic oncology; to address challenging topics in malignant thoracic diseases, including handling unfit patients with potentially curable lung cancer, wisely managing the side effects of immunotherapy in non-small cell lung cancer patients, selecting personalised multi-modal therapy options in malignant pleural mesothelioma patients and diagnosing and treating complicated mediastinal masses; to provide attendees with a unique opportunity to participate in interactive discussions with the case presenters and the on-stage multidisciplinary board panel.